Vigo is pleased to have been appointed by Acercor Therapeutics as strategic communications adviser to enhance their corporate reputation and investor communications. AIM-listed Arecor is a biopharmaceutical company focused on drug development and delivery in diabetes and other cardiometabolic disease.

Author